Abstract Details

Title Autoantibody Prediction of Risk for Thyroid Adverse Events after Alemtuzumab Treatment for Relapsing Multiple Sclerosis

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 091

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Alastair Compston, PhD, FRCP	No disclosure on file
	No disclosure on file
Ian M. Grant, MD (Northwestern University)	No disclosure on file

��ɫ��